Glenmark Pharmaceuticals Ltd slips for fifth straight session

Image
Capital Market
Last Updated : Jan 17 2023 | 2:04 PM IST

Glenmark Pharmaceuticals Ltd is quoting at Rs 414.75, down 1.27% on the day as on 13:19 IST on the NSE. The stock tumbled 16.25% in last one year as compared to a 0.89% slide in NIFTY and a 8.05% fall in the Nifty Metal index.

Glenmark Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quoting at Rs 414.75, down 1.27% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.32% on the day, quoting at 17951.35. The Sensex is at 60319.53, up 0.38%.Glenmark Pharmaceuticals Ltd has eased around 0.48% in last one month.Meanwhile, Nifty Metal index of which Glenmark Pharmaceuticals Ltd is a constituent, has eased around 0.41% in last one month and is currently quoting at 12659.4, down 0.51% on the day. The volume in the stock stood at 1.53 lakh shares today, compared to the daily average of 10.83 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 414.95, down 1.33% on the day. Glenmark Pharmaceuticals Ltd tumbled 16.25% in last one year as compared to a 0.89% slide in NIFTY and a 8.05% fall in the Nifty Metal index.

The PE of the stock is 7.1 based on TTM earnings ending September 22.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 17 2023 | 1:35 PM IST

Next Story